What signal Lilly sends by stockpiling GLP-1 obesity pills ahead of FDA approval
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
Tag: GLP1
This Founder Built Natural GLP-1 Alternative Before the Boom
Opinions expressed by Entrepreneur contributors are their own. Key Takeaways Evolv co-founder Becca McCarthy saw a massive GLP-1 trend —…
We’re raising our price target on Eli Lilly as the GLP-1 leader delivers
Eli Lilly ‘s fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for diabetes and…
Novo Nordisk CEO on 2026 Forecast and GLP-1 Pricing
Novo Nordisk CEO Mike Doustdar discusses the company’s updated 2026 sales guidance, forecasting a decline of 5 to 13% at…
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to…
Dr. Drew Says GLP-1 Drugs May Have Helped Nick Reiner, But It’s Delicate Balance
Dr. Drew On Nick Reiner GLP-1s Could Have Prevented Murders Published January 12, 2026 12:40 PM PST Play video content…
Americold Realty Trust (COLD) Traded Down Due to the Popularity of GLP-1 Drugs
American Century Investments, an investment management company, released its third-quarter 2025 investor letter for the “American Century Investments Small Cap…
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of…
Oprah Reveals Use of GLP-1 Medications Led to Sobriety
Oprah Winfrey is feeling better than ever. While the media mogul has been candid about her use of GLP-1s for weight…
Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world…